eISSN: 2449-8238
ISSN: 2392-1099
Clinical and Experimental Hepatology
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
4/2020
vol. 6
 
Share:
Share:
abstract:
Review paper

Epidemiology of non-alcoholic fatty liver disease and risk of hepatocellular carcinoma progression

Krishna Chaitanya Thandra
1
,
Adam Barsouk
2
,
Kalyan Saginala
3
,
John Sukumar Aluru
4
,
Prashanth Rawla
5
,
Alexander Barsouk
6

  1. Department of Pulmonary and Critical Care Medicine, Sentara Virginia Beach General Hospital, Virginia Beach, VA, USA
  2. Sidney Kimmel Cancer Center, Jefferson University, Philadelphia, USA
  3. Plains Regional Medical Group Internal Medicine, Clovis, USA
  4. Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, USA
  5. Department of Medicine, Sovah Health, Martinsville, USA
  6. Allegheny Health Network, Pittsburgh, USA
Clin Exp HEPATOL 2020; 6, 4: 289–294
Online publish date: 2020/12/30
View full text Get citation
 
PlumX metrics:
Non-alcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease worldwide. Its incidence has grown alongside the increasing global prevalence of type 2 diabetes, obesity, and metabolic syndrome. The risk of progression to hepatocellular carcinoma for nonalcoholic steatohepatitis patients over 5 years is 8%, and despite targeted and immunotherapy treatment advances, HCC maintains a bleak 5-year survival of 19%. NAFLD’s primary risk factors are components of metabolic syndrome as well as possible sleep disturbances. NAFLD is most common among men 50-60 years of age, though incidence in women catches up after menopause. In the US, Hispanics are most likely to develop NAFLD and African Americans least likely, in part due to the prevalence of the PNPLA3 gene variant. With NAFLD risk factors especially prevalent in underserved populations and developing nations, public health interventions, earlier diagnosis, and novel treatments could curb the growing disease burden.
keywords:

risk factor, incidence, prevalence, etiology, mortality

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.